Matthew Taylor
Stock Analyst at Jefferies
(4.58)
# 990
Out of 5,126 analysts
677
Total ratings
56.1%
Success rate
7.6%
Average return
Main Sectors:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Rated: Buy | $210 → $242 | $214.52 | +12.81% | 32 | Nov 5, 2026 | |
| LIVN LivaNova | Rated: Buy | $80 → $120 | $90.98 | +31.90% | 14 | Nov 4, 2026 | |
| BAX Baxter International | Reiterated: Hold | $19 → $25 | $26.34 | -5.09% | 35 | Oct 29, 2026 | |
| BSX Boston Scientific | Downgraded: Hold | $60 → $46 | $45.13 | +1.93% | 55 | Oct 28, 2026 | |
| PODD Insulet | Reiterated: Buy | $400 → $190 | $150.03 | +26.64% | 31 | Oct 12, 2026 | |
| SYK Stryker | Reiterated: Buy | $455 → $405 | $318.79 | +27.04% | 36 | Sep 22, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $102 → $105 | $105.81 | -0.77% | 69 | Sep 11, 2026 | |
| ESTA Establishment Labs Holdings | Reiterated: Buy | $63 → $105 | $70.69 | +48.54% | 11 | Sep 8, 2026 | |
| MDT Medtronic | Reiterated: Hold | $95 | $101.61 | -6.51% | 41 | Sep 2, 2026 | |
| ABT Abbott Laboratories | Reiterated: Buy | $135 | $109.29 | +23.52% | 44 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $92 | $82.60 | +11.38% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $245 → $225 | $238.53 | -5.67% | 16 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $110 | $101.60 | +8.27% | 13 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $112 | $80.35 | +39.40% | 36 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $115 | $75.39 | +52.54% | 30 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $18.77 | n/a | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 → $12 | $18.39 | n/a | 3 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $21.92 | n/a | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $130 → $110 | $107.47 | n/a | 28 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $24.94 | n/a | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $0.002 | n/a | 4 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $449.53 | n/a | 24 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $215 → $145 | $156.33 | n/a | 32 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33.00 → $34.50 | $13.70 | n/a | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $16 → $15 | $13.73 | n/a | 23 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.5 → $6 | $10.42 | n/a | 3 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $14.77 | n/a | 16 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $105 | $50.77 | n/a | 1 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $6.01 | n/a | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 364.00 → CHF 255.00 | CHF 282.80 | n/a | 13 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $230 | $321.72 | n/a | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $5.5 | $7.14 | n/a | 2 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $160.21 | n/a | 2 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €49.00 | €27.13 | n/a | 21 | Jan 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $43.52 | n/a | 1 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1.5 → $1 | $5.76 | n/a | 9 | Mar 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 → $16 | $12.42 | n/a | 2 | Jul 19, 2017 |
Becton, Dickinson and Company
Nov 5, 2026
Rated: Buy
Price Target: $210 → $242
Current: $214.52
Upside: +12.81%
LivaNova
Nov 4, 2026
Rated: Buy
Price Target: $80 → $120
Current: $90.98
Upside: +31.90%
Baxter International
Oct 29, 2026
Reiterated: Hold
Price Target: $19 → $25
Current: $26.34
Upside: -5.09%
Boston Scientific
Oct 28, 2026
Downgraded: Hold
Price Target: $60 → $46
Current: $45.13
Upside: +1.93%
Insulet
Oct 12, 2026
Reiterated: Buy
Price Target: $400 → $190
Current: $150.03
Upside: +26.64%
Stryker
Sep 22, 2026
Reiterated: Buy
Price Target: $455 → $405
Current: $318.79
Upside: +27.04%
Edwards Lifesciences
Sep 11, 2026
Reiterated: Buy
Price Target: $102 → $105
Current: $105.81
Upside: -0.77%
Establishment Labs Holdings
Sep 8, 2026
Reiterated: Buy
Price Target: $63 → $105
Current: $70.69
Upside: +48.54%
Medtronic
Sep 2, 2026
Reiterated: Hold
Price Target: $95
Current: $101.61
Upside: -6.51%
Abbott Laboratories
Aug 21, 2026
Reiterated: Buy
Price Target: $135
Current: $109.29
Upside: +23.52%
Jul 30, 2026
Reiterated: Buy
Price Target: $90 → $92
Current: $82.60
Upside: +11.38%
Jul 10, 2026
Reiterated: Hold
Price Target: $245 → $225
Current: $238.53
Upside: -5.67%
Mar 18, 2026
Reiterated: Buy
Price Target: $105 → $110
Current: $101.60
Upside: +8.27%
Feb 13, 2026
Reiterated: Buy
Price Target: $112
Current: $80.35
Upside: +39.40%
Jan 8, 2026
Reiterated: Buy
Price Target: $105 → $115
Current: $75.39
Upside: +52.54%
Nov 7, 2025
Reiterated: Buy
Price Target: $48
Current: $18.77
Upside: n/a
Oct 3, 2025
Reiterated: Hold
Price Target: $15 → $12
Current: $18.39
Upside: n/a
Aug 25, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $21.92
Upside: n/a
Aug 7, 2025
Reiterated: Hold
Price Target: $130 → $110
Current: $107.47
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $28
Current: $24.94
Upside: n/a
Jun 4, 2025
Reiterated: Buy
Price Target: $18
Current: $0.002
Upside: n/a
May 2, 2025
Reiterated: Hold
Price Target: n/a
Current: $449.53
Upside: n/a
May 1, 2025
Reiterated: Hold
Price Target: $215 → $145
Current: $156.33
Upside: n/a
Apr 28, 2025
Reiterated: Buy
Price Target: $33.00 → $34.50
Current: $13.70
Upside: n/a
Apr 14, 2025
Upgraded: Buy
Price Target: $16 → $15
Current: $13.73
Upside: n/a
Mar 4, 2025
Reiterated: Sell
Price Target: $0.5 → $6
Current: $10.42
Upside: n/a
Jul 16, 2024
Reiterated: Buy
Price Target: $50 → $48
Current: $14.77
Upside: n/a
Feb 1, 2024
Reiterated: Hold
Price Target: $105
Current: $50.77
Upside: n/a
Jan 19, 2024
Initiated Coverage: Buy
Price Target: $14
Current: $6.01
Upside: n/a
Oct 28, 2022
Reiterated: Hold
Price Target: CHF 364.00 → CHF 255.00
Current: CHF 282.80
Upside: n/a
Oct 12, 2022
Initiated Coverage: Buy
Price Target: $230
Current: $321.72
Upside: n/a
Mar 1, 2022
Reiterated: Hold
Price Target: $7 → $5.5
Current: $7.14
Upside: n/a
Feb 7, 2022
Upgraded: Buy
Price Target: n/a
Current: $160.21
Upside: n/a
Jan 25, 2022
Reiterated: Buy
Price Target: €49.00
Current: €27.13
Upside: n/a
Dec 6, 2019
Reiterated: Hold
Price Target: n/a
Current: $43.52
Upside: n/a
Mar 8, 2018
Reiterated: Sell
Price Target: $1.5 → $1
Current: $5.76
Upside: n/a
Jul 19, 2017
Reiterated: Hold
Price Target: $17 → $16
Current: $12.42
Upside: n/a